Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PRO ELITE INC | 413,920,000 | reported | 20 Dec 2012 | tx 6+248,352,000 |
| CervoMed Inc. | 204,907 | reported | 31 Aug 2016 | tx 3+309,797 |
| X4 Pharmaceuticals, Inc | 70,796 | reported | 13 Mar 2019 | tx 3+148,446 |
| PREMIER ALLIANCE GROUP, INC. | 25,000 | reported | 22 Jul 2016 | tx 14+9,786,318−7,192,856 |
| MEDGENICS, INC. | 20,000 | reported | 15 Apr 2016 | tx 15+2,031,828−325,183 |
| NASTECH PHARMACEUTICAL CO INC | 16,875 | reported | 16 Apr 2018 | tx 7+1,271,987.95 |
| InspireMD, Inc. | 12,500 | reported | 07 Dec 2016 | tx 3+841,024 |
| PDS Biotechnology Corp | 10,000 | reported | 15 Mar 2019 | tx 8+80,000−20,000 |
| Avalo Therapeutics, Inc. | 8,519 | reported | 31 Dec 2018 | tx 19+384,901−4,210,808 |
| CONTRAFECT Corp | 8,000 | reported | 25 Jul 2017 | tx 2+24,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Mar 2019 | EXERCISE | PDS Biotechnology Corp | 10,000 | 0.00 USD | |
| 15 Mar 2019 | EXERCISE | PDS Biotechnology Corp | 10,000 | 0.00 USD | deriv |
| 15 Mar 2019 | EXERCISE | PDS Biotechnology Corp | 10,000 | 0.00 USD | |
| 15 Mar 2019 | EXERCISE | PDS Biotechnology Corp | 10,000 | 0.00 USD | deriv |
| 13 Mar 2019 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 70,796 | — | deriv |
| 31 Dec 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 8,519 | 0.00 USD | deriv |
| 28 Sept 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 6,041 | 0.00 USD | deriv |
| 14 Aug 2018 | GRANT_AWARD | PDS Biotechnology Corp | 10,000 | 0.00 USD | deriv |
| 29 Jun 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 6,881 | 0.00 USD | deriv |
| 19 Jun 2018 | GRANT_AWARD | PDS Biotechnology Corp | 20,000 | 0.00 USD | deriv |
| 15 May 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 8,357 | 0.00 USD | deriv |
| 16 Apr 2018 | CONVERSION | NASTECH PHARMACEUTICAL CO INC | 777,750 | 0.00 USD | deriv |
| 16 Apr 2018 | CONVERSION | NASTECH PHARMACEUTICAL CO INC | 103.7 | 5000.00 USD | deriv |
| 16 Apr 2018 | GRANT_AWARD | NASTECH PHARMACEUTICAL CO INC | 16,875 | 0.00 USD | deriv |
| 16 Apr 2018 | GRANT_AWARD | NASTECH PHARMACEUTICAL CO INC | 2.25 | 5000.00 USD | deriv |
| 16 Apr 2018 | CONVERSION | NASTECH PHARMACEUTICAL CO INC | — | 0.00 USD | deriv |
| 31 Mar 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 6,111 | 0.00 USD | deriv |
| 31 Dec 2017 | GRANT_AWARD | Avalo Therapeutics, Inc. | 8,267 | 0.00 USD | deriv |
| 03 Jan 2018 | GRANT_AWARD | NASTECH PHARMACEUTICAL CO INC | 3,800 | 0.00 USD | deriv |
| 22 Nov 2017 | GRANT_AWARD | NASTECH PHARMACEUTICAL CO INC | 473,457 | 0.00 USD | deriv |
| 30 Sept 2017 | GRANT_AWARD | Avalo Therapeutics, Inc. | 27,560 | 0.00 USD | deriv |
| 30 Jun 2017 | GRANT_AWARD | Avalo Therapeutics, Inc. | 8,357 | 0.00 USD | deriv |
| 25 Jul 2017 | PURCHASE | CONTRAFECT Corp | 16,000 | 1.24 USD | |
| 25 Jul 2017 | PURCHASE | CONTRAFECT Corp | 8,000 | 0.01 USD | derivfirst after silence |
| 30 Jun 2017 | GRANT_AWARD | Avalo Therapeutics, Inc. | 36,982 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 25 Jul 2017.